⭐️ Update on longer outcomes with ribociclib (Kisqali) and abemaciclib (Verzenio) in hormone receptor positive/HER2 negative early stage breast cancer. ⭐️ These are CDK 4/6 inhibitors given in conjunction with endocrine therapy to reduce risk of recurrence. (CDK 4/6 inhibitors are standard of care in the treatment HR metastatic breast cancer as well). In early stage BC, abemaciclib is taken for 2 years and ribociclib for 3 years. In this video, I share with you recent updates (they are positive!
4:04
⭐️ Update on longer outcomes with ribociclib (Kisqali) and abema…
20.5K views7 months ago
FacebookEleonora Teplinsky, MD
Adding ribociclib to hormone therapy improves outcomes for patients with early breast cancer: Study
Adding ribociclib to hormone therapy improves outcomes for pa…
Jun 4, 2023
theprint.in
In this video, I discuss ribociclib and abemaciclib in early stage HR /HER2- breast cancer. Both are CDK 4/6 inhibitors which interfere with the cell cycle and are used in combination with endocrine therapy to decrease the risk of recurrence. Ribociclib: 400 mg daily 21 days on/7 days off for 3 years At 5 years: absolute improvement in invasive disease free survival (survival without disease) was 4.5% in patients receiving ribociclib (81% in endocrine therapy alone versus 85.5% in ribociclib end
3:33
In this video, I discuss ribociclib and abemaciclib in early stage HR /HE…
13.6K views5 months ago
FacebookEleonora Teplinsky, MD
Ribociclib in Early Breast Cancer | NEJM
2:00
Ribociclib in Early Breast Cancer | NEJM
4K viewsMar 28, 2024
YouTubeNEJM Group
NATALEE and monarchE: ribociclib and abemaciclib in HR+/HER2- breast cancer
1:48
NATALEE and monarchE: ribociclib and abemaciclib in HR+/HER2- bre…
755 viewsMay 20, 2024
YouTubeVJOncology
Ribociclib plus endocrine therapy boosts survival of HR+/HER2- breast cancer
2:44
Ribociclib plus endocrine therapy boosts survival of HR+/HER2- bre…
3.8K viewsJun 4, 2019
YouTubeMDedge: news and insights for busy physicians
Drug found to reduce risk of breast cancer coming back
1:27
Drug found to reduce risk of breast cancer coming back
Jun 2, 2023
ABC7 ChicagoSony Salzman
1:51
NATALEE: ribociclib and NSAI in HR+/HER2- early breast cancer
741 viewsSep 16, 2024
YouTubeVJOncology
Recent Updates on the NATALEE Trial: Ribociclib ET in Early Breas…
Mar 1, 2025
vumedi.com
Ribociclib Kisqali Medication uses, side effects & Lowest cost
Jun 11, 2024
rumble.com
7:18
Kisqali (Ribociclib) for Breast Cancer: Uses, Side Effects, and W…
20.7K viewsJul 7, 2024
YouTubeYerbba – Breast Cancer
1:41
ADAPT trial: Endocrine + ribociclib vs. chemotherapy in HR+/HER2- e…
565 viewsFeb 28, 2024
YouTubeVJOncology
Differentiating Between Abemaciclib and Ribociclib | OncLive
3 months ago
onclive.com
6:37
Adjuvant Ribociclib in Early Stage HR+ Breast Cancer: Clinical Insights
1K views4 months ago
YouTubeOncUpdates: Latest Oncology Insights
12:58
The Science Behind Kisqali: Understanding how this Targeted …
2.6K viewsSep 21, 2023
YouTubeInevid
3:09
Dr Mouabbi on the Use of Ribociclib vs Abemaciclib in HR+/HER2– Bre…
781 viewsJul 1, 2024
YouTubeOncLive
Rethinking Ribociclib: Is 400 mg Noninferior to 600 mg for Metastat…
7 months ago
medscape.com
1:35
Ribociclib plus letrozole is tied to longer progression-free survival t…
3.9K viewsMar 10, 2022
FacebookThe New England Journal of Medicine
7:14
Ribociclib for HR+ Advanced Breast Cancer
2.3K viewsMar 2, 2017
YouTubeOncLive
4:48
FDA Approves Ribociclib (Kisqali) for Stage 2-3 HR+/HER2- Breast C…
1.9K viewsSep 18, 2024
YouTubeEleonora Teplinsky, MD
0:59
Dr. Kelly on the FDA Approval of Ribociclib in HR+ Breast Cancer
1.3K viewsMar 13, 2017
YouTubeOncLive
10:15
MONALEESA-3 OS results: fulvestrant/ribociclib in postmeno…
1K viewsSep 29, 2019
YouTubeVJOncology
1:11
Using Ribociclib in the First-Line Setting
838 viewsMay 22, 2017
YouTubeOncLive
2:56
Ribociclib mejora la supervivencia del cáncer de mama HR1-positivo/…
2.1K viewsApr 10, 2024
YouTubeCONECTIMED
0:27
Toxicities Associated with Ribociclib From MONALEESA-3 Tr…
531 viewsOct 14, 2019
YouTubeOncLive
2:23
LEADER: ribociclib plus endocrine therapy reduces ctDNA in high-ris…
135 views5 months ago
YouTubeVJOncology
3:08
Adding ribociclib to endocrine therapy shows an improvement in …
760 viewsJul 3, 2023
YouTubeecancer
2:46
RIGHT Choice: ribociclib + ET vs combo chemo in aggressive HR+/…
2.5K viewsDec 12, 2022
YouTubeVJOncology
0:55
Novartis' New Breast Cancer Drug | Kisqali® | N18S | CNBC TV18
7.1K viewsSep 18, 2024
YouTubeCNBC-TV18
9:04
Ribociclib improves progression-free survival in advanced breast c…
Aug 11, 2017
Vimeoecancer
See more videos
Static thumbnail place holder